Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
The New Zealand Medical Journal|November 7, 2024
Holding a mirror to society? The socio-demographic characteristics of students commencing health professional programmes, and all courses, at Ōtākou Whakaihu Waka (the University of Otago), 1994-2023Andrew Sise, Sam Feeney, Griffin Manawaroa Leonard, et al.International Journal for Equity in Health|May 6, 2025
Equity, power and resources in primary health care reform: insights from Aotearoa New ZealandJohanna Reidy, Nina Bevin, Don Matheson, et al.Diabetes, Obesity & Metabolism|December 23, 2019
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID studyGeorge Grunberger, Anuj Bhargava, Trang Ly, et al.JAMA|July 4, 2017
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical TrialCarol Wysham, Anuj Bhargava, Louis Chaykin, et al.Current Medical Research and Opinion|April 19, 2012
Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial)Bruce S Trippe, Mark D Shepherd, Franklin C Coulter, et al.The American Journal of Medicine|October 27, 2009
A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial)David S Oyer, Mark D Shepherd, Franklin C Coulter, et al.International Journal of Health Services : Planning, Administration, Evaluation|August 27, 2005
Does community-governed nonprofit primary care improve access to services? Cross-sectional survey of practice characteristicsPeter Crampton, Peter Davis, Roy Lay-Yee, et al.Clinical Therapeutics|July 12, 2011
Efficacy and tolerability of self-titrated biphasic insulin aspart 70/30 in patients aged >65 years with type 2 diabetes: an exploratory post hoc subanalysis of the INITIATEplus trialDavid S Oyer, Mark D Shepherd, Franklin C Coulter, et al.Clinical Diabetes : a Publication of the American Diabetes Association|February 2, 2019
Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 TrialLouis Chaykin, Anuj Bhargava, Raymond de la Rosa, et al.NEJM Evidence|June 23, 2025
Semaglutide in Adults with Type 1 Diabetes and ObesityViral N Shah, Halis K Akturk, Davida Kruger, et al.Pageof 13